Atezolizumab Combo Numerically Improves pCR in HER2+ Operable Breast Cancer
Treatment with atezolizumab among patients with HER2-positive breast cancer in the phase 3 APTneo Michelangelo trial produces no major tolerability issues, says Luca Gianni, MD.
Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery
Govindarajan Narayanan, MD, speaks to the potential time-saving advantages of using the Epione robot for microwave ablation, cryoablation, and other surgical strategies in patients with liver cancer and other tumors.
Metabolism, Genetics May Impact Tumor Biology in Breast Cancer Populations
Latin American patients appear more likely to be diagnosed with aggressive early-stage breast cancer based on factors including metabolics and genetics, according to findings from the FLEX study.
Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment
Personalized therapy tailored for mutation status is something to expect in the coming years for colorectal cancer treatment, notes Tanios S. Bekaii-Saab, MD.
T-DM1 Improves OS/iDFS Vs Trastuzumab in HER2+ Breast Cancer
Investigators observe no new safety signals with trastuzumab emtansine as a treatment for HER2-positive breast cancer after 8 years of follow-up in the phase 3 KATHERINE study.
FDA Approves Isavuconazonium Sulfate for Pediatric Fungal Infections
Patients who are under the age of 17 with invasive mucormycosis or invasive aspergillosis, which is an AE of leukemia, can now receive isavuconazonium sulfate following FDA approval
2 Clarke Drive Cranbury, NJ 08512